Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

143.06 +0.05 (+0.03%)
Official Closing Price Updated: 7:00 PM EDT, Sep 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,751,571
Open 142.07
Bid (Size) 141.60 (5)
Ask (Size) 143.50 (1)
Prev. Close 143.01
Today's Range 140.95 - 143.42
52wk Range 106.86 - 175.91
Shares Outstanding N/A
Dividend Yield 3.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market
Eli Lilly leads medical stocks setting up and showing relative strength. 
Via Investor's Business Daily
Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery
 
Via Benzinga

Performance

YTD
+5.64%
+5.64%
1 Month
+4.92%
+4.92%
3 Month
-6.58%
-6.58%
6 Month
-11.68%
-11.68%
1 Year
+32.81%
+32.81%

More News

Read More
European Authority Backs AbbVie's Crohn's Disease Candidate
Via Benzinga
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
Via Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
Via InvestorPlace
AbbVie Psoriatic Arthritis Drug Shows Long-term Effect On Skin, Joint Symptoms
Via Benzinga
What Are Whales Doing With AbbVie
Via Benzinga
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
Via Investor's Business Daily
Analyzing AbbVie's Short Interest
Via Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
Via Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
Via Benzinga
This Is What Whales Are Betting On AbbVie
Via Benzinga
Dividend Income Update August 2022
Via Talk Markets
Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment
Via InvestorPlace
Death Cross Looms Over AbbVie Investors
Via Benzinga
Some Breast Implant Cases Are Associated With Skin Cancer, FDA Receives Reports
Via Benzinga
7 S&P 500 Stocks to Buy With Superior Fundamentals
Via InvestorPlace
Why Is Revance Therapeutics (RVNC) Stock Soaring Today?
Via InvestorPlace
AbbVie, Tesla, Financial Select Sector SPDR, iShares 20 Plus Year Treasury Bond And This Airline Are CNBC's Final Trades
Via Benzinga
Tesla, AbbVie Are CNBC 'Fast Money' Mentions; Steve Weiss Is Shorting This ETF
Via Benzinga
Ironwood's Constipation Drug Shows Efficacy In Pediatric Patients
Via Benzinga
Looking At AbbVie's Recent Whale Trades
Via Benzinga
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
Via CannabisNewsWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
This Stock 'Benefits From Volatility,' Analyst Says On CNBC's Final Trades, Plus AbbVie And ETF Plays
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.